PT  - JOURNAL ARTICLE
AU  - Mosley, Mary
ED  - Hendriks, Lizza E.
TI  - Prognostic Factors Identified in Stage IV NSCLC
DP  - 2015 Jun 19
TA  - MD Conference Express
PG  - 16--17
VI  - 15
IP  - 8
4099  - http://mdc.sagepub.com/content/15/8/16.2.short
4100  - http://mdc.sagepub.com/content/15/8/16.2.full
AB  - Single-organ metastasis and a low TN status (especially in combination), limited local metastasis, and active anticancer treatment are prognostic for a longer overall survival in patients with stage IV non–small cell lung cancer, according to a retrospective analysis using the National Cancer Registry in The Netherlands. Overall survival is longer in patients whose disease is staged using 18-fluoro-deoxyglucose positron emission tomography imaging.